SAILIFE1,591.50

Sai Life Sciences Ltd.

· Pharma & Health
₹ CrorePeersSYNGENEDIVISLABPPLPHARMANHNEULANDLABNATCOPHARMLALPATHLABCOHANCEMcap ₹33,705 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Non-current Assets
+ Property, Plant & Equipment1,477.41,808.71,808.7
+ Capital Work-in-Progress124.5270.5270.5
+ Other Intangibles10.96.16.1
+ Non-current Investments1.93.53.5
+ Other Non-current Financial Assets5.157.857.8
Non-current Financial Assets7.061.361.3
+ Deferred Tax Assets14.213.413.4
+ Other Non-current Assets21.655.655.6
Total Non-current Assets1,655.52,215.62,215.6
Current Assets
+ Inventories118.9151.0151.0
+ Current Investments0.047.047.0
+ Trade Receivables354.8373.6373.6
+ Cash & Cash Equivalents91.181.981.9
+ Other Bank Balances372.829.029.0
+ Other Current Financial Assets79.6104.0104.0
Current Financial Assets898.3635.5635.5
+ Other Current Assets487.4624.1624.1
Total Current Assets1,504.51,410.51,410.5
Total Assets3,160.03,626.13,626.1
Equity
+ Equity Share Capital20.821.221.2
+ Other Equity / Reserves2,107.52,462.52,462.5
Equity — Owners of Parent2,128.42,483.72,483.7
Total Equity2,128.42,483.72,483.7
Liabilities
+ Borrowings — Non-current0.020.520.5
+ Other Non-current Financial Liab164.7127.6127.6
Non-current Financial Liabilities164.7148.1148.1
+ Provisions — Non-current23.432.332.3
+ Deferred Tax Liabilities111.0128.3128.3
Non-current Liabilities299.1308.8308.8
+ Borrowings — Current128.674.674.6
+ Trade Payables322.5285.3285.3
+ Other Current Financial Liab134.5229.4229.4
Current Financial Liabilities585.6589.3589.3
+ Provisions — Current10.820.020.0
+ Current Tax Liabilities8.051.751.7
+ Other Current Liabilities128.1172.6172.6
Current Liabilities732.5833.7833.7
Total Liabilities1,031.61,142.51,142.5
Total Equity & Liabilities3,160.03,626.13,626.1
Trade Payables — MSME split
+ Dues to Micro & Small — Current47.443.043.0
+ Dues to Other Creditors — Current275.1242.4242.4
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.